Oral sustained release nystatin tablets for the treatment of oral candidiasis: formulation development and validation of UV spectrophotometric analytical methodology for content determination

References

• Tommasi AF. (1998). Diagnóstico em Patologia Bucal. In: Pancast, ed., p. 196, 197, 202. São Paulo.
   Google Scholar
• Neville BW, Damm DD, Allen CM, Bouquot JE. (1998). Patologia Oral & Maxilofacial. In: Guanabara-Koogan ( Ed.), ( pp. 176–204, 190, 700). Rio de Janeiro.
   Google Scholar
• Menezes EA, Sá KM, Cunha FA., Ângelo MRF, Oliveira IRN, Salviano MNC. (2005). Freqüência e atividade enzimática de Candida albicans isoladas da mucosa bucal de crianças de uma creche da prefeitura de Fortaleza. J Bras Patol Med Lab, 43(3):9–13.
   Google Scholar
• Leigh JE, Shetty K, Fidel PL. Jr. (2004). Oral opportunistic infections in HIV-positive individuals: review and role of mucosal immunity. AIDS Patients Care STDs, 18(8):443–56.
   PubMed Web of Science ®Google Scholar
• Akpan A, Morgan R. (2002). Oral Candidiasis. Postgraduate Med J, 78:455–459.
   PubMed Web of Science ®Google Scholar
• Ship J, Vissink A, Challacombe S. (2007). Use of prophylactic antifungals in the immunocompromised host. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 103: S6.e1–S6.e14.
   PubMed Web of Science ®Google Scholar
• Ellepola ANB, Samaranyake, LP. (2000). Antimycotics agents in oral candidosis: an overview. Crit Review Oral Biol Med, 11:172–198.
   PubMedGoogle Scholar
• Tavares W. (2001). Manual de Antibióticos e Quimioterápicos Antiinfecciosos. In: Atheneu, ed., p. 20–21, 747–749, 758–759. Rio de Janeiro.
   Google Scholar
• Gilman AG., Hardman JG, Limbird LE. (2003). As Bases Farmacológicas da Terapêutica. In: McGraw-Hill Interamericana do Brasil, ed., ( pp.413, 867, 971–972, 982). Rio de Janeiro, Brasil.
   Google Scholar
• Eptein JB, Polsky, B. (1998). Orapharyngeal candidiasis: a review of its clinical sprectrum and current therapies. Clin Ther, 20(l):40–57.
   PubMedGoogle Scholar
• Farah CS, Ashman RB, Challacombe, SJ. (2000). Oral candidosis. Clin Dermatol, 18(5):553–562.
   PubMed Web of Science ®Google Scholar
• Patton LL, Bonito AJ, Shugars DA. (2001). A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 92(2):170–179.
   PubMed Web of Science ®Google Scholar
• Sidrim JJC, Moreira JLB. (2004). Micologia Médica à Luz dos Autores Contemporâneos. In: Guanabara Koogan, ed., Rio de Janeiro.
   Google Scholar
• Baccaglini L, Atkinson JC, Patton LL, Glick M, Ficarra G, Peterson DE. (2007). Management of oral lesions in HIV-positive patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 103(Suppl. S50):e1–e23.
   PubMedGoogle Scholar
• Groeschke J, Solassol I, Bressolle F, Pinguet F. (2006). Stability of amphotericin B and nystatin in antifungal mouthrinses containing sodium hydrogen carbonate. J Pharm Biom Anal, 42:362–366.
   PubMed Web of Science ®Google Scholar
• Hac-Wydro K, Dynarowicz-Latka P. (2006a). Interation between nystatin and natural membrane lipids in Lagmuir monolayers—the role of a phospholipids in the mechanism of polyenes mode of action. Biophys Chem, 123:154–161.
   PubMed Web of Science ®Google Scholar
• Hac-Wydro K, Dynarowicz-Latka P. (2006b). Nystatin in Langmiur monolayres at the air/water interface. Colloids Surf B Biointerfaces, 53:64–71.
   PubMed Web of Science ®Google Scholar
• Casiglia JW., Woo S. (2000). Oral manifestations of HIV infection. Clin Dermatol, 18:541–551.
   PubMed Web of Science ®Google Scholar
• Dorocka-Bobkowska B, Konopka K, Düzgünes, N. (2003). Influence of antifungical polyenes on the adhesion of Candida albicans and Candida glabrata to human epithelial cells in vitro. Arch Oral Biol, 48(12):805–814.
   PubMed Web of Science ®Google Scholar
• Silva L, Coutinho A, Fedorova A, Prieto M. (2006). Nystatin-induced lipid vesicles permeabilization is strongly dependent of sterol structure. Bioch Biophys Acta, 1758(4), 452–459.
   PubMed Web of Science ®Google Scholar
• Croy SR, Known, GS. (2004). The effects of Pluronic block aggregation state of nystatin. J Control Rel, 95(2):161–171.
   PubMed Web of Science ®Google Scholar
• Codd JE, Deasy PB. (1998). Formulation and development and in vivo evaluation of a novel bioadhesive lozenge containing a synergistic combination of antifungal agensts. Int J Pharmacol, 173:13–24.
   Google Scholar
• Gupta VK, Hariharan M, Wheatley TA, Price JC. (2001). Controlled-release tablets from carrageenans: effect of formulation, storage and dissolution factors. Eur J Pharm Biopharm, 51:241–248.
   PubMed Web of Science ®Google Scholar
• United States Pharmacopeia (2008). In: Rockville, ed., The United States Pharmacopeial Convention, p. 103–109, 630, 2786.
   Google Scholar
• Brazilian Pharmacopoeia (1998). 4th ed. São Paulo, Brasil: Atheneu Editora.
   Google Scholar
• ICH Topic Q2B Note for Guidance on Validation of Analytical Procedures: Methodology GPMP/ICH/28 1/95. (1996).
   Google Scholar
• Martindale: The Complete Drug Reference. (1999). 32 th ed. In London Pharmaceutical Press, ed., 386 p.
   Google Scholar
• Aksungur P, Sungur A, Unal S, Iskit AB, Squier CA, Senel S. (2004). Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies. J Control Rel, 98(2):269–279.
   PubMed Web of Science ®Google Scholar
• Llabot JM, Manzo RH, Allemandi DA. (2003). Double-layered mucoadhesive tablets containing nystatin. AAPS Pharm Sci Tech, 3:1–6.
   Google Scholar
• Llabot JM., Manzo RH, Allemandi DA. (2004). Drug release from carbomer: carbomer sodium matrices with potencial use as mucoadhesive drug delivrey system. Int J Pharm, 276:59–66.
   PubMedGoogle Scholar
• Cappello B, De Rosa G, Giannini L, La Rotonda MI, Mensitieri G, Miro A, . (2006). Cyclodextrin-containing poly(ethylenooxide) tablets for the delivery of poorly soluble drugs: potencial as buccal delivery system. Int J Pharmacol, 319:79–85.
   Google Scholar
• Lubbers S, Guichard E. (2003). The effects of sugars and pectin on flavour release from a fruit pastilles model system. Food Chem, 81:269–273.
   Web of Science ®Google Scholar
• Azarmi S, Roa W, Löbenberg R. (2006). Current perspectives in dissolution testing of conventional and novel dosage forms. Int J Pharmaceut, 328(1):12–21.
   PubMed Web of Science ®Google Scholar